Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Cooking Pressure

<< Previous

Bullboard Posts

Next >>

Comment by m00nsh0tson Feb 01, 2023 7:12pm

250 Views

Post# 35260999

RE:Cooking Pressure

Are you kidding me? Do you know how many tens of thousands of people whose lives could've been extended if oncy had just added to the protocol the fact that what seems like sepsis is just the virus working and the physicians just need to ride it out. Those patients all died anyway after being pulled from the trial. Many here on this board knew the signs of the virus working.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant